EyePoint Pharmaceuticals
EYPT
EYPT
58 hedge funds and large institutions have $101M invested in EyePoint Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
19% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 16
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
64% less call options, than puts
Call options by funds: $58K | Put options by funds: $159K
Holders
58
Holding in Top 10
1
Calls
$58K
Puts
$159K
Top Buyers
| 1 | +$5.69M | |
| 2 | +$1.22M | |
| 3 | +$577K | |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$534K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$528K |
Top Sellers
| 1 | -$2.04M | |
| 2 | -$1.69M | |
| 3 | -$1.68M | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$892K |
| 5 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$589K |